Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by TechTargeton Oct 26, 2015 11:15pm
221 Views
Post# 24229342

TA Indicators BULLISH on CXR

TA Indicators BULLISH on CXRThere's a short clown parade on the board today. Enjoy it because it won't last long. The TA has already started to turn and many indicators are turning. Investors have clued in the sector wide shorting attack.

The bashing crews of short clows are in overdrive!

23 Oct 2015 Relative Strength Index (RSI) Short-term Bullish 43.71 --
23 Oct 2015 MACD Short-term Bullish 43.71 --
23 Oct 2015 Williams %R Short-term Bullish 43.71 --
23 Oct 2015 Slow Stochastic Short-term Bullish 43.71

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities